Previous Article | Next Article ![]()
Journal of Virology, May 2001, p. 4482-4489, Vol. 75, No. 10
Department of Pathology, Tulane Cancer
Center, New Orleans, Louisiana 70112
Received 7 November 2000/Accepted 2 February 2001
While Epstein-Barr virus (EBV) latency-associated gene expression
is associated with cell cycle progression, the relationship between the
EBV lytic program and the cell cycle is less clear. Using four
different EBV lytic induction systems, we address the relationship
between lytic cycle activation and the cell cycle. In three of these
systems, G0 or G1 cell growth arrest signaling is observed prior to detection of the EBV immediate-early gene product
Zta. In tetradecanoyl phorbol acetate-treated P3HR1 cultures and in
5-iodo-2'-deoxyuridine-treated NPC-KT cultures, cell cycle analysis of
Zta-expressing cell populations showed a significant G1
bias during the early stages of lytic cycle progression. In contrast,
treatment of the cell line Akata with anti-immunoglobulin (Ig) results
in rapid induction of immediate-early gene expression, and accordingly,
activation of the immediate-early gene product Zta precedes significant
anti-Ig-induced cell cycle effects. Nevertheless, cell cycle analysis
of the Zta-expressing population following anti-Ig treatment shows a
bias for cells in G1, indicating that anti-Ig-mediated
induction of Zta occurs more efficiently in cells traversing
G1. Last, although 5-azacytidine treatment of Rael cells
results in a G1 arrest in the total cell population which precedes the induction of Zta, cell cycle analysis of the
Zta-expressing population shows a significant bias for cells with an
apparent G2/M DNA content. This bias may result, in part,
from activation of Zta expression following demethylation of the Zta
promoter during S-phase. Together, these studies indicate that
induction of Zta occurs through several distinct mechanisms, some of
which may involve checkpoint signaling.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4482-4489.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cell Cycle Analysis of Epstein-Barr Virus-Infected
Cells following Treatment with Lytic Cycle-Inducing Agents

*
Corresponding author. Mailing address: Department of
Pathology, SL79, Tulane Cancer Center, 1430 Tulane Ave., New Orleans, LA 70112. Phone: (504) 988-1167. Fax: (504) 588-5516. E-mail: erik{at}flemingtonlab.com.
Present address: Centro de Biologia Molecular "Severo Ochoa,"
Facultad de Ciencias-Edif. Biologicas, Universidad Autonoma de Madrid,
28049 Cantoblanco, Madrid, Spain.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»